Friday March 23, 2018
22 Mar 2018 – Cost of antibiotic-resistant infections in U.S. tops $2B per year
Fierce Healthcare – 22nd March 2018 The Fierce Healthcare article entitled “Costs of antibiotic-resistant infections in U.S. tops $2Bn per year” can be found via the link below: https://bit.ly/2G3CdsM
Friday March 23, 2018
23 Mar 2018 – Destiny Pharma to announce financial results for the year ended 31 D...
Destiny Pharma will announce its financial results for the year ended 31 December 2017 on Thursday 12 April 2018.
Thursday March 22, 2018
22 Mar 2018 – Appointment of Joint Broker
Destiny Pharma (AIM: DEST), announces the appointment of finnCap Ltd as joint broker to the Company with immediate effect. Cantor Fitzgerald Europe remains nominated adviser and joint broker to the […]
Thursday March 15, 2018